BTIG analyst Justin Zelin has recently started covering IDEAYA Biosciences (NASDAQ: IDYA) and has given it a Buy rating with a Price Target of $55. This optimistic evaluation shows faith in the company’s future prospects. The Buy rating and price target suggest a promising forecast for IDEAYA Biosciences’ stock performance in the market.
IDYA Stock Shows Strong Performance on March 8, 2024 with Positive Price Momentum
On March 8, 2024, IDYA stock showed strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. This indicates positive price momentum for the stock.
IDYA shares opened at $46.27, which was $1.04 higher than its previous close. Throughout the trading day, the stock saw a price increase of $1.09, resulting in a 2.41% rise in its value. This upward movement in price reflects investor confidence and bullish sentiment towards IDYA.
IDYA Stock Sees Significant Decrease in Revenue and Net Income in 2024
On March 8, 2024, IDYA stock experienced a significant decrease in total revenue compared to the previous year and quarter. According to data from CNN Money, the company reported total revenue of $23.39 million for the past year, which represents a 54.08% decrease from the previous year. In the fourth quarter of the same year, IDYA reported total revenue of $3.92 million, marking a 51.19% decrease from the previous quarter.
Similarly, IDYA also reported a decline in net income for the past year and quarter. The company reported a net income of -$112.96 million for the past year, representing a 92.59% decrease from the previous year. In the fourth quarter, IDYA reported a net income of -$33.95 million, which remained unchanged from the previous quarter.
Furthermore, IDYA’s earnings per share (EPS) also saw a decrease compared to the previous year, but remained stable from the previous quarter. The company reported an EPS of -$1.96 for the past year, marking a 38.76% decrease from the previous year. In the fourth quarter, IDYA reported an EPS of -$0.52, which remained unchanged from the previous quarter.
Overall, IDYA stock performance on March 8, 2024, was characterized by declining total revenue and net income compared to the previous year and quarter. Investors may need to closely monitor IDYA’s financial performance and market trends to make informed decisions about their investments in the company.
